Article Deregulating Psychedelics To Propel Clinical Research This article explores the need to deregulate certain psychedelic drugs, including MDMA and psilocybin, which could help people living with PTSD and treatment-resistant depression as pharmaceuti
Technology Networks,
The following article is an opinion piece written by Colin Callaghan, Hugo Geerts and Patrick Loebs.